down arrow

Strides Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE939A01011
  • NSEID: STAR
  • BSEID: 532531
INR
607.45
24.75 (4.25%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 2.17 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Part of MojoOne Strategy
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Divi's Lab.
Hikal
Innova Captab
Cipla
Strides Pharma
Sun Pharma.Inds.
Torrent Pharma
Mankind Pharma
Unichem Labs.
SPARC
Orchid Pharma
Why is Strides Pharma Science Ltd ?
1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 6.00%
  • Poor long term growth as Net Sales has grown by an annual rate of 8.61% and Operating profit at 1.20% over the last 5 years
  • Low ability to service debt as the company has a high Debt to EBITDA ratio of 6.85 times
2
54.25% of Promoter Shares are Pledged
  • In falling markets, high promoter pledged shares puts additional downward pressure on the stock prices
  • The proportion of pledged holdings has increased by 5.08% over the last quarter
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Strides Pharma for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Strides Pharma
50.77%
1.09
46.57%
SENSEX
0.45%
0.03
14.48%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
8.61%
EBIT Growth (5y)
1.20%
EBIT to Interest (avg)
1.08
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.70
Tax Ratio
23.46%
Dividend Payout Ratio
-6.68%
Pledged Shares
54.25%
Institutional Holding
45.41%
ROCE (avg)
5.59%
ROE (avg)
2.78%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
21
Industry P/E
33
Price to Book Value
2.36
EV to EBIT
11.50
EV to EBITDA
8.83
EV to Capital Employed
1.72
EV to Sales
1.65
PEG Ratio
0.03
Dividend Yield
0.43%
ROCE (Latest)
13.32%
ROE (Latest)
7.40%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

25What is working for the Company
PAT(HY)

At Rs 164.96 cr has Grown at 98.12 %

PBT LESS OI(Q)

At Rs 110.66 cr has Grown at 319.00 %

ROCE(HY)

Highest at 10.46 %

INVENTORY TURNOVER RATIO(HY)

Highest at 3.59 times

OPERATING PROFIT TO INTEREST(Q)

Highest at 4.03 times

DEBT-EQUITY RATIO(HY)

Lowest at 1.02 times

EPS(Q)

Highest at Rs 9.54

-1What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Strides Pharma
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 110.66 cr has Grown at 319.00 %
Year on Year (YoY)
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 89.87 cr has Grown at 80.9 %
Year on Year (YoY)
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Operating Profit to Interest - Quarterly
Highest at 4.03 times
in the last five quarters
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Inventory Turnover Ratio- Half Yearly
Highest at 3.59 times and Grown
each half year in the last five half yearly periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 110.66 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 89.87 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 9.54
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Debt-Equity Ratio - Half Yearly
Lowest at 1.02 times
in the last five half yearly periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio